Baron and Budd GranuFlo Lawsuit Lawyers Reviewing Claims Made By Dialysis Patients Allegedly Injured by GranuFlo

Filing of GranuFlo lawsuits is on the rise as the GranuFlo recall alleges serious side effect risk associated with GranuFlo use

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend

Los Angeles, CA (PRWEB) September 30, 2013

The GranuFlo recall lawyers at Baron and Budd are reviewing GranuFlo claims relating to the March 2012 GranuFlo and NaturaLyte recall. A dialysis concentrate used during dialysis to help clean the blood, both GranuFlo and NaturaLyte are manufactured and marketed by Fresenius Medical Care, the world's largest provider of dialysis products. Both dialysis concentrates were recalled by the Food and Drug Administration (FDA) as a Class I recall, the highest form of drug recall in the United States used only when a medical product poses a serious risk of death or other serious injury. (http://www.fda.gov/MedicalDevices/Safety/ListofRecalls/ucm309990.htm)

Dialysis patients or their loved ones may be eligible to file a GranuFlo lawsuit with Baron and Budd's GranuFlo recall lawyers if they suffered from a heart attack during or following a dialysis treatment. This dialysis treatment may have involved the use of GranuFlo or NaturaLyte and could be responsible for the patient's alleged injury.

At this time, Baron and Budd is continuing to review GranuFlo lawsuit claims, providing individuals who may be eligible to file a GranuFlo lawsuit claim with free and confidential legal consultation.

The risk of heart attack associated with the administration of GranuFlo and NaturaLyte has to do with the increased bicarbonate associated with the dialysis concentrates. Both GranuFlo and NaturaLyte are more likely to cause a higher level of bicarbonate in the blood compared to other dialysis concentrates in their class. As doctors were uninformed of this risk of increased bicarbonate associated with GranuFlo and NaturaLyte, patients were in turn put at risk for heart attacks allegedly caused by an overdose of bicarbonate. (http://www.prweb.com/releases/2013/5/prweb10700127.htm)

"The FDA does not take Class I recalls lightly, instead these recalls occur only when serious risk of death or other serious injury is posed by these products. While the Class I recall is an important step in ensuring dialysis patient safety, more needs to be done to help patients who have already been injured by the drug's risk of increasing bicarbonate in the blood. Our GranuFlo lawyers are taking the necessary steps to help these injured patients by providing confidential and free consultations with patients who have suffered from heart attack following dialysis treatment," says Russell Budd of Baron and Budd.

To learn more about Baron and Budd's handling of the GranuFlo lawsuit please visit the firm's website at http://baronandbudd.com/areas-of-practice/pharmaceuticals/granuflo-lawyer/

To speak with a GranuFlo lawyer as part of Baron and Budd's free and confidential GranuFlo recall consultations, please call 1.866.472.9108.

ABOUT BARON & BUDD
With the large resources and size needed to tackle intricate dangerous drug and medical device cases, Baron and Budd is a nationally recognized law firm with an impressive record of protecting patient safety. Baron and Budd is able to handle cases in every state across the country and has permanent offices in Dallas, Austin, Los Angeles and Baton Rouge. With over three and a half decades "Protecting What's Right," Baron and Budd has won game-changing cases benefiting patient health across the country. Recently, Baron and Budd was chosen as a Public Justice 2013 Trial Lawyer of the Year Award Finalist.


Contact